Veteran Owned
Over 30 Years of Experience
Opening Hours
Mon-Fri: 8AM - 5PM

Abbott, Dexcom could benefit from CGM use jump among Type 2 diabetes patients: report

The population could drive the next wave of demand for devices to track and control diabetes, Jefferies analysts predict, following a recent CMS coverage change that rolled back restrictions to CGM access.

Leave a Reply

Your email address will not be published. Required fields are marked *